title: Choice of appropriate endpoints for a balloon versus stent trial.
authors.forename: Jonathon M
authors.initials: JM
authors.lastname: White
authors.forename: Mark W
authors.initials: MW
authors.lastname: Webster
authors.forename: John A
authors.initials: JA
authors.lastname: Ormiston
mesh_terms: D015906:Angioplasty, Balloon, Coronary; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage*; D023903:Coronary Restenosis / Q000517:prevention & control*; D005260:Female; D006801:Humans; D008297:Male; D017239:Paclitaxel / Q000008:administration & dosage*
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D017239:Paclitaxel